APP and Alzheimer disease: On the other hand, exogenous administration of LF has shown to stimulate the non-amyloidogenic processing of amyloid precursor protein and α-secretase activity, with a consequent reduction in Aβ deposition that ameliorates cognitive decline in mouse models of AD [22].